The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.5M data for 728K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Tritium-labelled isovaleryl-RYYRIK-NH2 as potential antagonist probe for ORL1 nociceptin receptor.EBI
Kyushu University
20(S)-Ginsenoside Rh2 as aldose reductase inhibitor from Panax ginseng.EBI
Kyushu University
Functional characterization of mouse cation transporter mOCT2 compared with mOCT1.EBI
Kyushu University
Synthesis of 61-bis(1-adamantylcarbamoyl)-1,2-methano[60]fullerene and its antagonistic effect on haloperidol-induced catalepsy in mice.EBI
Kyushu University
Spare interactions of highly potent [Arg(14),Lys(15)]nociceptin for cooperative induction of ORL1 receptor activation.EBI
Kyushu University
Designed modification of partial agonist of ORL1 nociceptin receptor for conversion into highly potent antagonist.EBI
Kyushu University
Differential receptor binding characteristics of consecutive phenylalanines in micro-opioid specific peptide ligand endomorphin-2.EBI
Kyushu University
Discriminatory synergistic effect of Trp-substitutions in superagonist [(Arg/Lys)(14), (Arg/Lys)(15)]nociceptin on ORL1 receptor binding and activation.EBI
Kyushu University
Discovery of Chlorofluoroacetamide-Based Covalent Inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 3CL Protease.EBI
Kyushu University
Direct evidence of edge-to-face CH/π interaction for PAR-1 thrombin receptor activation.EBI
Kyushu University
An electrochemical device for the assay of the interaction between a dioxin receptor and its various ligands.EBI
Kyushu University
Solid-Phase synthesis of a library constructed of aromatic phosphate, long alkyl chains and tryptophane components, and identification of potent dipeptide telomerase inhibitors.EBI
Kyushu University
Bisphenol AF: Halogen bonding effect is a major driving force for the dual ERα-agonist and ERβ-antagonist activities.EBI
Kyushu University
Development of novel telomerase inhibitors based on a bisindole unit.EBI
Kyushu University
Early identification of promiscuous attributes of aldose reductase inhibitors using a DMSO-perturbation assay.EBI
Kyushu University
Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure.EBI
Kyushu University
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.EBI
Kyushu University
Identification of the 5,5-dioxo-7,8-dihydro-6H-thiopyrano[3,2-d]pyrimidine derivatives as highly selective PDE4B inhibitors.EBI
Kyushu University
Synthesis and biological evaluation of 5-carbamoyl-2-phenylpyrimidine derivatives as novel and potent PDE4 inhibitors.EBI
Kyushu University
Ambuic acid inhibits the biosynthesis of cyclic peptide quormones in gram-positive bacteria.EBI
Kyushu University
Design and synthesis of benzoacridines as estrogenic and anti-estrogenic agents.EBI
Kyushu University
Heteroaryl compounds and uses thereofBDB
Celgene Car